Cargando…
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
INTRODUCTION: Biomarkers of Alzheimer's disease (AD) that can easily be measured in routine health checkups are desirable. Urine is a source of biomarkers that can be collected easily and noninvasively. We previously reported on the comprehensive profile of the urinary proteome of AD patients a...
Autores principales: | Watanabe, Yumi, Hirao, Yoshitoshi, Kasuga, Kensaku, Tokutake, Takayoshi, Kitamura, Kaori, Niida, Shumpei, Ikeuchi, Takeshi, Nakamura, Kazutoshi, Yamamoto, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548924/ https://www.ncbi.nlm.nih.gov/pubmed/33082773 http://dx.doi.org/10.1159/000509561 |
Ejemplares similares
-
Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients
por: Watanabe, Yumi, et al.
Publicado: (2019) -
Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
por: Watanabe, Yumi, et al.
Publicado: (2021) -
Urinary proteome profiles associated with cognitive decline in community elderly residents—A pilot study
por: Watanabe, Yumi, et al.
Publicado: (2023) -
A Patient with Fragile X-Associated Tremor/Ataxia Syndrome Presenting with Executive Cognitive Deficits and Cerebral White Matter Lesions
por: Kasuga, Kensaku, et al.
Publicado: (2011) -
Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)